Cargando…

Myocardial Bridging

Myocardial bridging is rare. Myocardial bridges are most commonly localized in the middle segment of the left anterior descending coronary artery. The anatomic features of the bridges vary significantly. Alterations of the endothelial morphology and the vasoactive agents impact on the progression of...

Descripción completa

Detalles Bibliográficos
Autor principal: Yuan, Shi-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cirurgia Cardiovascular 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062697/
https://www.ncbi.nlm.nih.gov/pubmed/27074276
http://dx.doi.org/10.5935/1678-9741.20150082
_version_ 1782459833746718720
author Yuan, Shi-Min
author_facet Yuan, Shi-Min
author_sort Yuan, Shi-Min
collection PubMed
description Myocardial bridging is rare. Myocardial bridges are most commonly localized in the middle segment of the left anterior descending coronary artery. The anatomic features of the bridges vary significantly. Alterations of the endothelial morphology and the vasoactive agents impact on the progression of atherosclerosis of myocardial bridging. Patients may present with chest pain, myocardial infarction, arrhythmia and even sudden death. Patients who respond poorly to the medical treatment with β-blockers warrant a surgical intervention. Myotomy is a preferred surgical procedure for the symptomatic patients. Coronary stent deployment has been in limited use due to the unsatisfactory long-term results.
format Online
Article
Text
id pubmed-5062697
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Sociedade Brasileira de Cirurgia Cardiovascular
record_format MEDLINE/PubMed
spelling pubmed-50626972016-10-19 Myocardial Bridging Yuan, Shi-Min Braz J Cardiovasc Surg Review Articles Myocardial bridging is rare. Myocardial bridges are most commonly localized in the middle segment of the left anterior descending coronary artery. The anatomic features of the bridges vary significantly. Alterations of the endothelial morphology and the vasoactive agents impact on the progression of atherosclerosis of myocardial bridging. Patients may present with chest pain, myocardial infarction, arrhythmia and even sudden death. Patients who respond poorly to the medical treatment with β-blockers warrant a surgical intervention. Myotomy is a preferred surgical procedure for the symptomatic patients. Coronary stent deployment has been in limited use due to the unsatisfactory long-term results. Sociedade Brasileira de Cirurgia Cardiovascular 2016 /pmc/articles/PMC5062697/ /pubmed/27074276 http://dx.doi.org/10.5935/1678-9741.20150082 Text en http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Yuan, Shi-Min
Myocardial Bridging
title Myocardial Bridging
title_full Myocardial Bridging
title_fullStr Myocardial Bridging
title_full_unstemmed Myocardial Bridging
title_short Myocardial Bridging
title_sort myocardial bridging
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062697/
https://www.ncbi.nlm.nih.gov/pubmed/27074276
http://dx.doi.org/10.5935/1678-9741.20150082
work_keys_str_mv AT yuanshimin myocardialbridging